Purdue Settles Ark. Fund's OxyContin Antitrust Suit

Law360, New York (April 6, 2010, 5:24 PM EDT) -- An employee benefits fund in Arkansas has settled a suit accusing Purdue Pharmaceuticals LP of blocking generic competition by filing bogus patent litigation over OxyContin, marking the latest agreement in the drugmaker's continued effort to resolve all pending cases in the multidistrict litigation.

The Arkansas Carpenters Health and Welfare Fund agreed to drop its six-year-old suit against Purdue and Abbott Laboratories, which was named a defendant for its role in co-promoting OxyContin, according to a stipulation to dismiss the case with prejudice that was approved in...
To view the full article, register now.